Many observational studies have shown that HIV-infected patients are at an increased risk for developing a variety of cardiac diseases.  With the introduction of HAART, longevity of HIV-infected patients increased, in turn leading to increased prevalence of cardiac and allied diseases. Inflammation and immune regulation leading to atherogenesis, endothelial dysfunction and coagulation abnormalities have been proposed as the major factors in the pathogenesis of cardiovascular diseases in AIDS. Compared to age-matched uninfected controls, HIV-infected patients have a higher risk of myocardial infarction (MI) and cardiovascular death, even with effective anti-retroviral therapy.  Concerns have been raised about HAART by itself is associated with increased risk of peripheral (PAD) and coronary artery disease (CAD) .
Cardiac diseases in AIDS pathophysiology
HIV AIDS pathophysiology
Cardiac diseases in AIDS medical therapy
Cardiac diseases in AIDS laboratory findings
Cardiac diseases in AIDS epidemiology and demographics
Cardiac diseases in AIDS other diagnostic studies
HIV associated nephropathy risk factors
HIV Immune Complex Kidney Disease risk factors